Evaluation of Apelin, Elabela, and Certain Biomarkers in Patients with Metabolic Disease Associated with Obesity

Background: A novel peptide known as Elabela was recently discovered; it functions similarly to apelin and acts through apelin receptors. This research is to compare the characteristics and biological roles of apelin and Elabela in patients with metabolic syndrome who are obese and those who are no...

Full description

Saved in:
Bibliographic Details
Main Authors: Layla Imad Ali, Shaimaa Imad Ali, Fayhaa M. Khaleel, Wasan Saher Hassan, Kawther Adeeb Hussein, Great Iruoghene Edo
Format: Article
Language:English
Published: College of medicine/ University of Diyala 2025-06-01
Series:Diyala Journal of Medicine
Subjects:
Online Access:http://djm.uodiyala.edu.iq/index.php/djm/article/view/1187
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849319363972169728
author Layla Imad Ali
Shaimaa Imad Ali
Fayhaa M. Khaleel
Wasan Saher Hassan
Kawther Adeeb Hussein
Great Iruoghene Edo
author_facet Layla Imad Ali
Shaimaa Imad Ali
Fayhaa M. Khaleel
Wasan Saher Hassan
Kawther Adeeb Hussein
Great Iruoghene Edo
author_sort Layla Imad Ali
collection DOAJ
description Background: A novel peptide known as Elabela was recently discovered; it functions similarly to apelin and acts through apelin receptors. This research is to compare the characteristics and biological roles of apelin and Elabela in patients with metabolic syndrome who are obese and those who are not. Patients and Methods: A cross-sectional study included 90 participants, ages 20–45, whose samples were collected from Al-Yarmouk-Hospital/Al-Karkh/Baghdad, from April–July/2024. Classified into three groups: group1 was obese metabolic syndrome patients (N=30), group 2 was metabolic syndrome patients without obesity (N=30), and group 3 was control (N=30). Anthropometrics and parameters were assessed for all study groups. Fasting blood glucose levels and lipid profiles were determined using an enzymatic process with spectrophotometric methods, while insulin, apelin, and Elabela were evaluated by enzyme-linked immunosorbent assay. Results: The result shows a significant difference in Body Mass Index, Waist to Hip Ratio, Lipid profile, FBS, apelin, insulin, and HOMA-IR, while there was no significant difference between the study groups in Elabela levels. In addition, there is a positive correlation between apelin and BMI, FBS, and insulin. apelin levels have a higher diagnostic value for obesity than metabolic syndrome, respectively. Conclusion: This study suggests that apelin and Elabela are powerful modulators of the metabolism of adipose cell and highlights the crucial role of apelin in MetS in both non-obese and obese MetS, as well as in clinical and biochemical markers associated with obesity. Keywords: Apelin, APJ, Elabela, Metabolic Syndrome, Obesity.
format Article
id doaj-art-c916ca9036244d59aced193a3cc5d008
institution Kabale University
issn 2219-9764
2617-8982
language English
publishDate 2025-06-01
publisher College of medicine/ University of Diyala
record_format Article
series Diyala Journal of Medicine
spelling doaj-art-c916ca9036244d59aced193a3cc5d0082025-08-20T03:50:31ZengCollege of medicine/ University of DiyalaDiyala Journal of Medicine2219-97642617-89822025-06-0128210.26505/djm.v28i2.1187Evaluation of Apelin, Elabela, and Certain Biomarkers in Patients with Metabolic Disease Associated with ObesityLayla Imad Ali0Shaimaa Imad Ali1Fayhaa M. Khaleel2Wasan Saher Hassan3Kawther Adeeb Hussein4Great Iruoghene Edo5Department of Pharmaceutical Chemistry, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq.Department of Chemistry, College of science, Al-Nahrain University, Jadriya, Baghdad, Iraq.Department of Chemistry, College of Sciences for Women, University of Baghdad, Baghdad, Iraq.Department of Biochemistry, College of Medicine, University of Diyala, Diyala, Iraq.Department of Chemistry, College of science, Al-Nahrain University, Jadriya, Baghdad, Iraq.Department of Chemistry, Delta State University of Science and Technology, Ozoro, Nigeria. Background: A novel peptide known as Elabela was recently discovered; it functions similarly to apelin and acts through apelin receptors. This research is to compare the characteristics and biological roles of apelin and Elabela in patients with metabolic syndrome who are obese and those who are not. Patients and Methods: A cross-sectional study included 90 participants, ages 20–45, whose samples were collected from Al-Yarmouk-Hospital/Al-Karkh/Baghdad, from April–July/2024. Classified into three groups: group1 was obese metabolic syndrome patients (N=30), group 2 was metabolic syndrome patients without obesity (N=30), and group 3 was control (N=30). Anthropometrics and parameters were assessed for all study groups. Fasting blood glucose levels and lipid profiles were determined using an enzymatic process with spectrophotometric methods, while insulin, apelin, and Elabela were evaluated by enzyme-linked immunosorbent assay. Results: The result shows a significant difference in Body Mass Index, Waist to Hip Ratio, Lipid profile, FBS, apelin, insulin, and HOMA-IR, while there was no significant difference between the study groups in Elabela levels. In addition, there is a positive correlation between apelin and BMI, FBS, and insulin. apelin levels have a higher diagnostic value for obesity than metabolic syndrome, respectively. Conclusion: This study suggests that apelin and Elabela are powerful modulators of the metabolism of adipose cell and highlights the crucial role of apelin in MetS in both non-obese and obese MetS, as well as in clinical and biochemical markers associated with obesity. Keywords: Apelin, APJ, Elabela, Metabolic Syndrome, Obesity. http://djm.uodiyala.edu.iq/index.php/djm/article/view/1187ApelinAPJElabelaMetabolic SyndromeObesity
spellingShingle Layla Imad Ali
Shaimaa Imad Ali
Fayhaa M. Khaleel
Wasan Saher Hassan
Kawther Adeeb Hussein
Great Iruoghene Edo
Evaluation of Apelin, Elabela, and Certain Biomarkers in Patients with Metabolic Disease Associated with Obesity
Diyala Journal of Medicine
Apelin
APJ
Elabela
Metabolic Syndrome
Obesity
title Evaluation of Apelin, Elabela, and Certain Biomarkers in Patients with Metabolic Disease Associated with Obesity
title_full Evaluation of Apelin, Elabela, and Certain Biomarkers in Patients with Metabolic Disease Associated with Obesity
title_fullStr Evaluation of Apelin, Elabela, and Certain Biomarkers in Patients with Metabolic Disease Associated with Obesity
title_full_unstemmed Evaluation of Apelin, Elabela, and Certain Biomarkers in Patients with Metabolic Disease Associated with Obesity
title_short Evaluation of Apelin, Elabela, and Certain Biomarkers in Patients with Metabolic Disease Associated with Obesity
title_sort evaluation of apelin elabela and certain biomarkers in patients with metabolic disease associated with obesity
topic Apelin
APJ
Elabela
Metabolic Syndrome
Obesity
url http://djm.uodiyala.edu.iq/index.php/djm/article/view/1187
work_keys_str_mv AT laylaimadali evaluationofapelinelabelaandcertainbiomarkersinpatientswithmetabolicdiseaseassociatedwithobesity
AT shaimaaimadali evaluationofapelinelabelaandcertainbiomarkersinpatientswithmetabolicdiseaseassociatedwithobesity
AT fayhaamkhaleel evaluationofapelinelabelaandcertainbiomarkersinpatientswithmetabolicdiseaseassociatedwithobesity
AT wasansaherhassan evaluationofapelinelabelaandcertainbiomarkersinpatientswithmetabolicdiseaseassociatedwithobesity
AT kawtheradeebhussein evaluationofapelinelabelaandcertainbiomarkersinpatientswithmetabolicdiseaseassociatedwithobesity
AT greatiruogheneedo evaluationofapelinelabelaandcertainbiomarkersinpatientswithmetabolicdiseaseassociatedwithobesity